Mankind Pharma Limited
Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products.
What Mankind files
- Others66
- Investor Meet45
- Important38
- Updates35
- Board Meeting18
- Credit Ratings9
Mankind Pharma’s wholly-owned subsidiary, Bharat Serums and Vaccines, has received member approval to initiate voluntary liquidation. This strategic restructuring aims to streamline operations and optimize the corporate holding structure.
Mankind Pharma completed the sale of its entire 100% stake in Broadway Hospitality Services Private Limited to AKRK Projects LLP and its Partners. Broadway is no longer a wholly-owned subsidiary.
Mankind Pharma's Board approved consolidating its wholly-owned subsidiary, Bharat Serums and Vaccines (BSVL). BSVL's business will integrate into Mankind Pharma via voluntary liquidation, aiming to boost operational efficiency, optimize resources, and streamline business consolidation.
Mankind Pharma's independent ESG rating by CRISIL improved to 'Strong' (64) from 'Adequate' (57), with its Core ESG rising to 71. This reflects enhanced sustainability practices, potentially boosting long-term investor appeal.
Mankind Pharma signed an exclusive in-licensing deal with Chongqing Chenan Biopharmaceutical for two insulin analogues in India. This strengthens its diabetes segment presence and expands its injectable diabetes portfolio.